Abstract
The p16 gene (CDKN2) which is localized on chromosome 9p21, is deleted in a significant number of sporadic cancers1–3. Moreover, germline mutations identified in some melanoma-prone kindreds4,5 last year suggested that CDKN2 is identical to the 9p21 −linked melanoma susceptibility gene (MLM)6; however, failure to identify p16 mutations in all melanoma kindreds putatively linked to 9p21 left some doubts. We have analysed CDKN2 coding sequences in 15 Dutch familial atypical multiple mole-melanoma (FAMMM) syndrome pedigrees, and identified a 19 basepair (bp) germline deletion in 13 of them. All 13 families originate from an endogamous population. The deletion causes a reading frame shift, predicted to result in a severely truncated p16 protein. Interestingly, two family members are homozygous for the deletion, one of whom shows no obvious signs of disease. This surprising finding demonstrates that homozygotes for this CDKN2 mutation are viable, and suggests the presence of a genetic mechanism that can compensate for the functional loss of p16. Our results also greatly strengthen the notion that p16 is indeed MLM.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kamb, A. et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436–440 (1994).
Nobori, T. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753–756 (1994).
Serrano, M., Hannon, G.J. & Beach, D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704–707 (1993).
Kamb, A. et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet. 8, 22–26 (1994).
Hussussian, C.J. et al. Germline p16 mutations in familial melanoma. Nature Genet. 8, 15–21 (1994).
Cannon-Albright, L.A. et al. Assignment of a locus for familial melanoma MLM, to chromosome 9p13-p22. Science 258, 1148–1152 (1992).
Gruis, N.A. et al. Linkage analysis in Dutch familial atypical multiple mole-melanoma (FAMMM) syndrome families. Effect of naevus count. Melanoma Res. 3, 271–277 (1993).
Bergman, W., Gruis, N.A., Sandkuijl, L.A. & Frants, R.R. Genetics of seven Dutch familial atypical multiple mole-melanoma syndrome families: A review of linkage results including chromosomes 1 and 9. J. Invest. Dermat. 103, 122S–125S (1994).
Hannon, G.J. & Beach, D. p15INK4B is a potential effector of TGF- β-induced cell cycle arrest. Nature 371, 257–261 (1994).
Donehower, L.A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215–221 (1992).
Sah, V.P., Attardi, L.D., Mulligan, G.J., Williams, B.C., Bronson, R.T. & Jacks, T. A subset of p53-deficient embryos exhibit exencephaly. Nature Genet. 10, 175–180 (1995).
Lee, E.Y.-H.P. et al. Mice deficient for Rb are non viable and show defects in neurogenesis and haematopoiesis. Nature 359, 288–295 (1992).
Guan, K.-L. et al. Growth suppression by p18, a p16INK4/MTS1 and p14INK4B/MTS2- related CDK6 inhibitor, correlates with the wild-type pRb function. Genes Dev. 8, 2939–2952 (1994).
Bergman, W., Gruis, N.A. & Frants, R.R. The Dutch FAMMM family material: Clinical and genetic data. Cytogenet. cell. Genet. 59, 161–164 (1992).
Miller, S.A., Dykes, D.D. & Polesky, H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res. 16, 1215 (1988).
Orita, M., Suzuki, Y., Sekiya, T. & Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5, 874–879 (1989).
Maniatis, T., Fritsch, E.F. & Sambrook, J. in Molecular Cloning: A Laboratory Manual 2nd edn (Cold Spring Habor Laboratory Press, Cold Spring Habor, 1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gruis, N., van der Velden, P., Sandkuijl, L. et al. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet 10, 351–353 (1995). https://doi.org/10.1038/ng0795-351
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0795-351
This article is cited by
-
CDKN2A germline alterations and the relevance of genotype-phenotype associations in cancer predisposition
Hereditary Cancer in Clinical Practice (2021)
-
Pathways from senescence to melanoma: focus on MITF sumoylation
Oncogene (2017)
-
Pancreatic Cancer Screening
Current Treatment Options in Gastroenterology (2017)
-
A germline mutation of CDKN2A and a novel RPLP1-C19MC fusion detected in a rare melanotic neuroectodermal tumor of infancy: a case report
BMC Cancer (2016)
-
Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity
Familial Cancer (2016)